First-line immune defences against COVID-19 are short-lived and may explain reinfection
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in ...
A new study finds that antibodies produced in the nose decline nine months after COVID-19 infection, while antibodies found in ...
Individuals previously infected with SARS-CoV-2, the virus that causes COVID-19, still benefit from vaccination, gaining 60% to 94% protection against ...
Sending regular texts to young people who have recently had a sexually transmitted infection (STI) to encourage safer sex behaviours ...
Abstract: https://www.acpjournals.org/doi/10.7326/M21-4119 URLs go live when the embargo lifts A cohort study found that reinfection rates are low after successful ...
The Omicron variant of SARS-CoV-2 evades immunity from prior infection, an analysis of routine surveillance data from South Africa indicates. ...
In 2020 and early 2021, people who had been infected with SARS-CoV-2 had around 72% to 86% protection against reinfection ...
Highlights: Tracking new hotspots of SARS-CoV-2 will become more important as the virus evolves and becomes endemic. New variants may ...
We bring you the latest science news from best research centers and universities around the world. Check our website.
© 2022 Scienmag- Science Magazine: Latest Science News.
© 2022 Scienmag- Science Magazine: Latest Science News.